title: Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides.
authors.affiliation: Isis Pharmaceuticals, Inc., Carlsbad, CA 92008, USA. rgeary@isisph.com
authors.forename: R S
authors.initials: RS
authors.lastname: Geary
authors.forename: J M
authors.initials: JM
authors.lastname: Leeds
authors.forename: S P
authors.initials: SP
authors.lastname: Henry
authors.forename: D K
authors.initials: DK
authors.lastname: Monteith
authors.forename: A A
authors.initials: AA
authors.lastname: Levin
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000493:pharmacokinetics* / Q000494:pharmacology*; D013045:Species Specificity; D013873:Thionucleotides / Q000493:pharmacokinetics* / Q000494:pharmacology*; D014018:Tissue Distribution
chemical_list: D000970:Antineoplastic Agents; D016376:Oligonucleotides, Antisense; D013873:Thionucleotides